IL109626A0 - Stable quinolone and naphthydridine premix formulations - Google Patents

Stable quinolone and naphthydridine premix formulations

Info

Publication number
IL109626A0
IL109626A0 IL10962694A IL10962694A IL109626A0 IL 109626 A0 IL109626 A0 IL 109626A0 IL 10962694 A IL10962694 A IL 10962694A IL 10962694 A IL10962694 A IL 10962694A IL 109626 A0 IL109626 A0 IL 109626A0
Authority
IL
Israel
Prior art keywords
naphthydridine
quinolone
stable
premix formulations
premix
Prior art date
Application number
IL10962694A
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of IL109626A0 publication Critical patent/IL109626A0/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
IL10962694A 1993-05-15 1994-05-11 Stable quinolone and naphthydridine premix formulations IL109626A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US6244793A 1993-05-15 1993-05-15

Publications (1)

Publication Number Publication Date
IL109626A0 true IL109626A0 (en) 1994-08-26

Family

ID=22042549

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10962694A IL109626A0 (en) 1993-05-15 1994-05-11 Stable quinolone and naphthydridine premix formulations

Country Status (4)

Country Link
AU (1) AU6832394A (en)
IL (1) IL109626A0 (en)
WO (1) WO1994026110A1 (en)
ZA (1) ZA943317B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ID21415A (en) 1997-12-05 1999-06-10 Upjohn Co QUINOLON MAGNESIUM ANTIBIOTIC COMPOUNDS
US20090082337A1 (en) * 2007-09-21 2009-03-26 Srini Venkastesh Compositions Comprising Quinolone and Methods for Treating or Controlling Infections
GR1008168B (en) * 2013-03-14 2014-04-08 "Φαρματεν Α.Β.Ε.Ε.", Parenteral formulation of fluoroquinolone antibacterial agent and method for preparation thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3831514A1 (en) * 1988-09-16 1990-03-22 Bayer Ag PH NEUTRAL WAESSED SOLUTIONS OF CHINOLO CARBON ACIDS
US5225413A (en) * 1988-09-16 1993-07-06 Bayer-Aktiengesellschaft pH-neutral aqueous solutions of quinolone-carboxylic acids

Also Published As

Publication number Publication date
AU6832394A (en) 1994-12-12
ZA943317B (en) 1995-01-23
WO1994026110A1 (en) 1994-11-24

Similar Documents

Publication Publication Date Title
HU9600932D0 (en) In-alkyl-n-arylpyrimidinamines and derivatives thereof
IL111978A0 (en) Dry-compressed paroxetine formulations and their preparation
IL106109A0 (en) Vaccine compositions and their manufacture
GB9525977D0 (en) Perfluoroelastomeric compositions and methods
EP0721328A4 (en) Camptothecin formulations
AU4939693A (en) Combination pin pad and terminal
AU5494294A (en) Hop extract and use thereof
AP9901623A0 (en) Pharmaceutical formulations comprising amoxocyllin and clavulanate
ZA9410235B (en) Slow-release insect-repellent formulations and uses
GB9410252D0 (en) Galenic formulations
GB9214390D0 (en) Formulations
HUP0000460A3 (en) Imidazopyridazines and pharmaceutical compositions thereof
GB9114526D0 (en) Compositions and use thereof
IL109626A0 (en) Stable quinolone and naphthydridine premix formulations
GB9103631D0 (en) Composition and use
GB9722958D0 (en) Galenical formulations
ZA942246B (en) Novel imidazolo-quinoxalinones their preparation and use
GB9216776D0 (en) Composition and use
GB9303098D0 (en) Burner plaque
GB9416404D0 (en) New use and formulations
GB9406858D0 (en) New use and formulations
ZA948902B (en) P-Hydroxyaniline derivatives their preparation and their use
ZA948901B (en) P-hydroxyaniline derivatives their preparation and their use
GB9301251D0 (en) Pharmaceutical compositions and use therefor
GB9315200D0 (en) New use and compositions